Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells

Fa,Jing

doi:10.3892/ol.2021.12785

Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells

Authors:
- Jing Fa
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Linyi Cancer Hospital, Linyi, Shandong 276000, P.R. China
Published online on: May 12, 2021 https://doi.org/10.3892/ol.2021.12785
Article Number: 524
Copyright: © Fa . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dynamin 3 (DNM3) functions as a tumor suppressor in various malignancies. However, the underlying mechanism of DNM3 in cervical cancer remains to be elucidated. The present study aimed to indicate the function of DNM3 in cervical cancer. The expression of DNM3 in cervical tissues and cells was measured using bioinformatics analysis, immunohistochemistry and reverse transcription‑quantitative PCR. The pcDNA3.1 plasmid was used to overexpress DNM3 in SiHa and C33A cells. The effects of DNM3 overexpression on cell proliferation, migration, invasion and apoptosis was detected by the CCK-8, clone formation, transwell, flow cytometry and western blotting assays. In the present study, it was revealed that DNM3 was expressed at significantly low levels in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines. In addition, the low expression of DNM3 was significantly associated with high pathological grading of cervical cancer. The overall survival rate of patients with low DNM3 expression was significantly improved compared with patients with high DNM3 expression. In addition, the overexpression of DNM3 significantly inhibited the proliferation, migration and invasion of cervical carcinoma cells and induced cell apoptosis. The findings of the present study further revealed that the overexpression of DNM3 may inhibit cell migration and invasion by inactivating the epithelial mesenchymal transition process. In summary, the present study demonstrated that DNM3 was a tumor suppressor in cervical cancer progression and that it may serve as a potential prognostic biomarker for patients with cervical carcinoma.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
3	Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G and Vlastos AT: Prognostic value of histopathology and trends in cervical cancer: A SEER population study. BMC Cancer. 7:1642007. View Article : Google Scholar : PubMed/NCBI
4	Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, et al: Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 134:1389–1398. 2014. View Article : Google Scholar : PubMed/NCBI
5	Xu XX, Zhou JS, Yuan SH, Yu H and Lou HM: Distribution of HPV genotype in invasive cervical carcinoma and cervical intraepithelial neoplasia in Zhejiang province, southeast China: Establishing the baseline for surveillance. Int J Environ Res Public Health. 12:10794–10805. 2015. View Article : Google Scholar : PubMed/NCBI
6	McDowell M, Pardee DJ, Peitzmeier S, Reisner SL, Agénor M, Alizaga N, Bernstein I and Potter J: Cervical cancer screening preferences among trans-masculine individuals: Patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health. 4:252–259. 2017. View Article : Google Scholar : PubMed/NCBI
7	Bosgraaf RP, Ketelaars PJ, Verhoef VM, Massuger LF, Meijer CJ, Melchers WJ and Bekkers RL: Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med. 64:108–113. 2014. View Article : Google Scholar : PubMed/NCBI
8	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
9	Heymann JA and Hinshaw JE: Dynamins at a glance. J Cell Sci. 122((Pt 19)): 3427–3431. 2009. View Article : Google Scholar : PubMed/NCBI
10	Raja SA, Shah STA, Tariq A, Bibi N, Sughra K, Yousuf A, Khawaja A, Nawaz M, Mehmood A, Khan MJ and Hussain A: Caveolin1 and dynamin2 overexpression is associated with the progression of bladder cancer. Oncol Lett. 18:219–226. 2019.PubMed/NCBI
11	Meng J: Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer. Oncotarget. 8:41701–41716. 2017. View Article : Google Scholar : PubMed/NCBI
12	Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, Takeda S, Fujiwara M, Koike M, Sugimoto H, et al: Dynamin 3: A new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. Onco Targets Ther. 6:1417–1424. 2013. View Article : Google Scholar : PubMed/NCBI
13	Zhang Z, Chen C, Guo W, Zheng S, Sun Z and Geng X: DNM3 attenuates hepatocellular carcinoma growth by activating P53. Med Sci Monit. 22:197–205. 2016. View Article : Google Scholar : PubMed/NCBI
14	Gu C, Yao J and Sun P: Dynamin 3 suppresses growth and induces apoptosis of hepatocellular carcinoma cells by activating inducible nitric oxide synthase production. Oncol Lett. 13:4776–4784. 2017. View Article : Google Scholar : PubMed/NCBI
15	Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1):W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Trepat X, Chen Z and Jacobson K: Cell migration. Compr Physiol. 2:2369–2392. 2012.PubMed/NCBI
18	Dietrich JB: Apoptosis and anti-apoptosis genes in the Bcl-2 family. Arch Physiol Biochem. 105:125–135. 1997.(In French). View Article : Google Scholar : PubMed/NCBI
19	Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C and Coll JL: Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol. 149:1941–1952. 1996.PubMed/NCBI
20	Levesley J, Steele L, Bruning-Richardson A, Davison A, Zhou J, Ding C, Lawler S and Short SC: Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells. Neuro Oncol. 20:203–214. 2018. View Article : Google Scholar : PubMed/NCBI
21	Suarez-Carmona M, Lesage J, Cataldo D and Gilles C: EMT and inflammation: Inseparable actors of cancer progression. Mol Oncol. 11:805–823. 2017. View Article : Google Scholar : PubMed/NCBI
22	Ma Y, Guan L, Han Y, Zhou Y, Li X, Liu Y, Zhang X, Zhang W, Li X, Wang S and Lu W: siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway. Cancer Manag Res. 11:5799–5811. 2019. View Article : Google Scholar : PubMed/NCBI
23	Yang JK, Yang JP, Tong J, Jing SY, Fan B, Wang F, Sun GZ and Jiao BH: Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma. J Neurooncol. 131:255–265. 2017. View Article : Google Scholar : PubMed/NCBI